Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("YANAGITANI, Noriko")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 29

  • Page / 2
Export

Selection :

  • and

Assessment of Therapy Response in Lung Cancer With 18F-α-Methyl Tyrosine PETKAIRA, Kyoichi; ORIUCHI, Noboru; YANAGITANI, Noriko et al.American journal of roentgenology (1976). 2010, Vol 195, Num 5, pp 1204-1211, issn 0361-803X, 8 p.Article

Forearm Muscle Metastasis as an Initial Clinical Manifestation of Lung CancerKAIRA, Kyoichi; ISHIZUKA, Tamotsu; YANAGITANI, Noriko et al.Southern medical journal (Birmingham, Ala. Print). 2009, Vol 102, Num 1, pp 79-81, issn 0038-4348, 3 p.Article

Small cell carcinoma of the larynx in a long- term survivor of small-cell lung cancerKAIRA, Kyoichi; ISHIZUKA, Tamotsu; SAHARA, Naondo et al.Journal of clinical oncology. 2006, Vol 24, Num 18, pp 2961-2963, issn 0732-183X, 3 p.Article

L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancerIMAI, Hisao; KAIRA, Kyoichi; ORIUCHI, Noboru et al.Histopathology. 2009, Vol 54, Num 7, pp 804-813, issn 0309-0167, 10 p.Article

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinomaKAIRA, Kyoichi; ORIUCHI, Noboru; MORI, Masatomo et al.Lung cancer. 2009, Vol 66, Num 1, pp 120-126, issn 0169-5002, 7 p.Article

Identification of D19S246 as a novel lung adenocarcinoma susceptibility locus by genome survey with 10-cM resolution microsatellite markersYANAGITANI, Noriko; KOHNO, Takashi; KIM, Jeong-Gyoon et al.Cancer epidemiology, biomarkers & prevention. 2003, Vol 12, Num 4, pp 366-371, issn 1055-9965, 6 p.Article

Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypesKOHNO, Takashi; KUNITOH, Hideo; HIROSE, Hiroshi et al.Carcinogenesis (New York. Print). 2010, Vol 31, Num 5, pp 834-841, issn 0143-3334, 8 p.Article

L-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasmsKAIRA, Kyoichi; ORIUCHI, Noboru; ENDOU, Hitoshi et al.Cancer science. 2008, Vol 99, Num 12, pp 2380-2386, issn 1347-9032, 7 p.Article

Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibilitySUNAGA, Noriaki; KOHNO, Takashi; YANAGITANI, Noriko et al.Cancer epidemiology, biomarkers & prevention. 2002, Vol 11, Num 8, pp 730-738, issn 1055-9965Article

Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancerKAIRA, Kyoichi; ORIUCHI, Noboru; KANAI, Yoshikatsu et al.Cancer science. 2009, Vol 100, Num 4, pp 753-758, issn 1347-9032, 6 p.Article

Diagnostic usefulness of fluorine-18-α-methyltyrosine positron emission tomography in combination with 18F -fluorodeoxyglucose in sarcoidosis patientsKAIRA, Kyoichi; ORIUCHI, Noboru; OTANI, Yoshimi et al.Chest. 2007, Vol 131, Num 4, pp 1019-1027, issn 0012-3692, 9 p.Article

Epigenetic inactivation of the RAS-effector gene RASSF2 in lung cancersKAIRA, Kyoichi; SUNAGA, Noriaki; TOMIZAWA, Yoshio et al.International journal of oncology. 2007, Vol 31, Num 1, pp 169-173, issn 1019-6439, 5 p.Article

Association of polymorphisms in the MTH1 gene with small cell lung carcinoma riskKOHNO, Takashi; SAKIYAMA, Tokuki; SASAKI-MATSUMURA, Rumie et al.Carcinogenesis (New York. Print). 2006, Vol 27, Num 12, pp 2448-2454, issn 0143-3334, 7 p.Article

Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrationsKUDO, Keita; OHYANAGI, Fumiyoshi; MINGYON MUN et al.Lung cancer. 2011, Vol 74, Num 3, pp 401-404, issn 0169-5002, 4 p.Article

Evaluation of thoracic tumors with 18F-FMT and 18F-FDG PET-CT : A clinicopathological studyKAIRA, Kyoichi; ORIUCHI, Noboru; KANAI, Yoshikatsu et al.International journal of cancer (Print). 2009, Vol 124, Num 5, pp 1152-1160, issn 0020-7136, 9 p.Article

Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lungKAIRA, Kyoichi; ORIUCHI, Noboru; NAKAJIMA, Takashi et al.Cancer science. 2009, Vol 100, Num 2, pp 249-254, issn 1347-9032, 6 p.Article

Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REVI and LIG4 with lung cancer riskSAKIYAMA, Tokuki; KOHNO, Takashi; KIMURA, Junko et al.International journal of cancer. 2005, Vol 114, Num 5, pp 730-737, issn 0020-7136, 8 p.Article

Inhibition of L-type Amino Acid Transporter 1 Has Antitumor Activity in Non-small Cell Lung CancerIMAI, Hisao; KAIRA, Kyoichi; NAKAJIMA, Takashi et al.Anticancer research. 2010, Vol 30, Num 12, pp 4819-4828, issn 0250-7005, 10 p.Article

Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancerSUNAGA, Noriaki; ORIUCHI, Noboru; KAIRA, Kyoichi et al.Lung cancer. 2008, Vol 59, Num 2, pp 203-210, issn 0169-5002, 8 p.Article

Proton pump inhibitor improves breath marker in moderate asthma with gastroesophageal reflux diseaseSHIMIZU, Yasuo; DOBASHI, Kunio; MORI, Masatomo et al.Respiration (Basel). 2007, Vol 74, Num 5, pp 558-564, issn 0025-7931, 7 p.Article

Fluorine -18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer : A Clinicopathologic StudyKAIRA, Kyoichi; ORIUCHI, Noboru; DOBASHI, Kunio et al.Clinical cancer research. 2007, Vol 13, Num 21, pp 6369-6378, issn 1078-0432, 10 p.Article

Association of the OGG1-Ser326Cys polymorphism with lung adenocarcinoma riskKOHNO, Takashi; KUNITOH, Hideo; TOYAMA, Kaoru et al.Cancer science. 2006, Vol 97, Num 8, pp 724-728, issn 1347-9032, 5 p.Article

Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1YANAGITANI, Noriko; KOHNO, Takashi; SUNAGA, Noriaki et al.Carcinogenesis (New York. Print). 2002, Vol 23, Num 7, pp 1177-1183, issn 0143-3334Article

A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancerKAIRA, Kyoichi; SUNAGA, Noriaki; YOSHII, Akihiro et al.Lung cancer. 2010, Vol 69, Num 1, pp 99-104, issn 0169-5002, 6 p.Article

Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancerKAIRA, Kyoichi; SUNAGA, Noriaki; HISADA, Takeshi et al.Lung cancer. 2010, Vol 68, Num 2, pp 253-257, issn 0169-5002, 5 p.Article

  • Page / 2